| Code: MTA11498 | Publication Date: Dec 2025 |
Growing adoption of minimally invasive procedures, rising stroke incidence, expanding hospital capacities, and enhanced imaging technologies support this industry’s rise. The market represented a notable share of over 18% within the broader interventional care ecosystem in 2025, reflecting a continued shift in treatment preferences across key healthcare settings.
Thrombectomy Devices Market trends indicate accelerating preference for advanced clot retrieval systems, faster procedural workflows, and stronger clinical adoption across stroke and vascular care settings. Manufacturers are enhancing aspiration performance, improving stent-retriever designs, and refining device-trackability for complex anatomy. Increased clinician training, improved hospital readiness, and expanding evidence-based protocols are also shaping purchase decisions and influencing adoption patterns across organised healthcare delivery networks.
There has been an increase in aspiration technology, developments in new technology out of mechanical thrombectomy devices, and a continued emphasis by stent retriever manufacturers on increasing the probability of a successful first pass retrieval. New engineers have developed improved methods to facilitate navigation throughout the vascular system and to facilitate controlled engagement of thrombus. Hybrid devices have gained significant traction in the marketplace due to the need for devices that can handle a variety of thrombus types.
Some of the leading companies include: